Recent Studies from Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University Add New Data to Non-Small Cell Lung Cancer (Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung ...)

Source :: Obesity, Fitness & Wellness Week. May 28, 2022, 1276
Publication Year :: 2022
Abstract: 2022 MAY 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on non-small cell lung cancer. According to news [...]

Subjects :: Docetaxel -- Research
Lung cancer, Small cell -- Research
Lung cancer, Non-small cell -- Research
Apoptosis -- Reports -- Research -- Economic aspects
Physical fitness -- Research -- Reports -- Economic aspects
Health

Tools